PDGFRA and central nervous system cancer: Flavahan and colleagues demonstrated that human IDH mutant gliomas exhibit hypermethylation at CTCF-binding sites, resulting in alteration 3D structure genome-wide and activation of the oncogene PDGFRA by allowing a constitutive enhancer to interact aberrantly with PDGFRA promoter [32].